Clinical Trial Update: Evaluating Additional Platelet Inhibition in Patients With High Platelet Reactivity Undergoing Percutaneous Coronary Intervention [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating additional platelet inhibition in patients with high platelet reactivity undergoing percutaneous coronary intervention; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Syndrome

Snippet

Sponsor: Royal Brompton & Harefield NHS Foundation Trust | Conditions: Cardiovascular Disease, Acute Coronary Syndrome | Phase 4 | Status: TERMINATED